235 results on '"Neal, K"'
Search Results
2. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
3. Gender differences with leadless pacemakers: Peri-procedural complications, long-term device function, and clinical outcomes
4. Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
5. LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician
6. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
7. Hypertrophic Cardiomyopathy as an Unexpected Mimic of Inducible Laryngeal Obstruction: The Case for Cardiopulmonary Exercise Testing in Otolaryngology
8. Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy
9. The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease
10. Cardiac Complications of Pregnancy in Desmoplakin Cardiomyopathy
11. PO-02-174 CHARACTERIZATION OF PAPILLARY MUSCLE ABLATION WITH OPTICAL MAPPING AT DIFFERENT TRANSMURAL PENETRATION DEPTHS IN LIVE HUMAN HEART
12. PO-03-058 S-ICD GENERATOR EXCHANGE AND PERFORMANCE: A SINGLE TERTIARY CARE EXPERIENCE
13. PO-04-196 MULTIVARIATE PREDICTORS OF MORTALITY IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIA: INSIGHTS FROM A COMMUNITY COHORT OF 24000 INDIVIDUALS
14. PO-01-211 LONG-TIME MACHINE-LEARNING PREDICTION OF COMPLEX SPATIOTEMPORAL DYNAMICS DURING FIBRILLATION IN LIVE EXPLANTED PIG AND HUMAN HEARTS
15. EN-452414-3 PREDICTORS OF ISCHEMIC STROKE IN THE YOUNG: SLEEP APNEA, RACE AND RISK FACTORS BEYOND AF AND CHADS2VASC
16. MP-453091-11 INCIDENCE, REASONS FOR, AND PREDICTORS OF DISCONTINUATION OF DOFETILIDE THERAPY
17. Editorial overview: Synthetic biomolecules for probing lipid membranes
18. WOMEN IN EXPLORER-HCM HAD MORE SEVERE HEART FAILURE AT BASELINE BUT SIMILAR, OR GREATER, RESPONSE TO MAVACAMTEN
19. COMPARISON OF COST BETWEEN PERCUTANEOUS VASCULAR CLOSURE COMPARED TO MANUAL COMPRESSION IN ATRIAL FIBRILLATION ABLATION: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL.
20. IMPROVEMENT IN MULTI-DOMAIN PATIENT-REPORTED OUTCOME SCORES WITH MAVACAMTEN TREATMENT IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE VALOR-HCM STUDY
21. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL
22. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS WITH OR WITHOUT HYPERTENSION: ANALYSIS OF THE EXPLORER-HCM TRIAL
23. OBSTRUCTIVE HCM PATIENTS IN EXPLORER-HCM WITH HIGH LEFT VENTRICULAR FILLING PRESSURES HAD MORE SEVERE HEART FAILURE BUT SIMILAR OR GREATER RESPONSE TO MAVACAMTEN
24. OBSTRUCTIVE SLEEP APNEA PORTENDS STROKE IN YOUNG INDIVIDUALS WITHOUT ATRIAL FIBRILLATION: A LARGE REGISTRY STUDY
25. 96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)
26. NOVEL USE OF TRANSCAVAL IMPELLA FOR HEMODYNAMIC SUPPORT FOR UNSTABLE VENTRICULAR TACHYCARDIA
27. Patellofemoral contact forces and knee gait mechanics 3 months after ACL reconstruction are associated with cartilage degradation 24 months after surgery
28. Hypertrophic Cardiomyopathy as an Unexpected Mimic of Inducible Laryngeal Obstruction: The Case for Cardiopulmonary Exercise Testing in Otolaryngology
29. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
30. The Road Not Yet Traveled: Distinction in Critical Care Cardiology through the Advanced Heart Failure and Transplant Cardiology Training Pathway
31. Synthetic probes and chemical tools in sphingolipid research
32. EN-452414-3 PREDICTORS OF ISCHEMIC STROKE IN THE YOUNG: SLEEP APNEA, RACE AND RISK FACTORS BEYOND AF AND CHADS2VASC
33. MP-453091-11 INCIDENCE, REASONS FOR, AND PREDICTORS OF DISCONTINUATION OF DOFETILIDE THERAPY
34. PO-04-196 MULTIVARIATE PREDICTORS OF MORTALITY IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIA: INSIGHTS FROM A COMMUNITY COHORT OF 24000 INDIVIDUALS
35. Direct observation of a stable spiral wave reentry in ventricles of a whole human heart using optical mapping for voltage and calcium
36. Spiral wave breakup: Optical mapping in an explanted human heart shows the transition from ventricular tachycardia to ventricular fibrillation and self-termination
37. 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders
38. Reducing Catheter-Associated Urinary Tract Infections Across a Hospital System Through Urine Culture Stewardship
39. Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain
40. Genetic Testing for Dilated Cardiomyopathy
41. Cardiac Complications of Pregnancy in Desmoplakin Cardiomyopathy
42. Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
43. Engineering materials for artificial cells
44. Percutaneous Vascular Closure Compared With Manual Compression in Atrial Fibrillation Ablation
45. PO-01-211 LONG-TIME MACHINE-LEARNING PREDICTION OF COMPLEX SPATIOTEMPORAL DYNAMICS DURING FIBRILLATION IN LIVE EXPLANTED PIG AND HUMAN HEARTS
46. PO-03-058 S-ICD GENERATOR EXCHANGE AND PERFORMANCE: A SINGLE TERTIARY CARE EXPERIENCE
47. Editorial overview: Synthetic biomolecules for probing lipid membranes
48. OBSTRUCTIVE SLEEP APNEA PORTENDS STROKE IN YOUNG INDIVIDUALS WITHOUT ATRIAL FIBRILLATION: A LARGE REGISTRY STUDY
49. NOVEL USE OF TRANSCAVAL IMPELLA FOR HEMODYNAMIC SUPPORT FOR UNSTABLE VENTRICULAR TACHYCARDIA
50. WOMEN IN EXPLORER-HCM HAD MORE SEVERE HEART FAILURE AT BASELINE BUT SIMILAR, OR GREATER, RESPONSE TO MAVACAMTEN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.